Scientists Solve Mystery Behind Statin Muscle Pain

Over 200 million people worldwide take statins to prevent heart attacks and strokes, but many quit because of painful muscle side effects. Scientists at the University of British Columbia just figured out why it happens, and the discovery could change everything.

The research team used advanced imaging technology to watch statins interact with muscle cells at the molecular level. What they found was startling: statins force open a protein channel called the ryanodine receptor, causing calcium to leak continuously into muscle tissue.

Think of it like a gate that's supposed to open only when muscles contract. Statins jam that gate open, flooding cells with calcium that becomes toxic over time. This explains why some patients feel muscle soreness and fatigue, while others develop more serious complications.

Dr. Steven Molinarolo, the study's lead author, explained that they could see "almost atom by atom" how three statin molecules cluster together inside the protein. The first molecule wedges in while the channel is closed, then two more lock into place and force it wide open.

The team focused on atorvastatin, one of the most prescribed statins globally, but they believe the same mechanism affects other drugs in the family. Their findings appeared in Nature Communications earlier this month.

Here's where it gets exciting: now that scientists know exactly which part of the statin molecule causes the problem, they can design new versions that avoid it. The drugs could keep their cholesterol-lowering power while leaving muscle tissue alone.

The Ripple Effect

While severe muscle damage affects only a small percentage of statin users, milder symptoms are common enough that many people stop taking their medication entirely. That decision puts them at higher risk for heart attacks and strokes, two of the leading causes of death worldwide.

Safer statins would mean more people could stay on treatment without suffering. For patients who've struggled with side effects for years, this research offers genuine hope for better options.

Dr. Filip Van Petegem, the senior author, emphasized that statins have been "a cornerstone of cardiovascular care for decades." His team's goal is simply to make them work better for everyone.

The breakthrough also showcases how cutting-edge imaging tools are accelerating medical progress. The cryo-electron microscopy facility at UBC captured details that would have been impossible to see just a few years ago.

For the millions who depend on statins to stay healthy, relief may finally be on the horizon.